Fred Ramsdell

Last updated

Fred Ramsdell
Fred Ramsdell, 2015 (cropped).jpg
Ramsdell in 2015
Born
Frederick Jay Ramsdell

(1960-12-04) December 4, 1960 (age 64)
Education University of California, San Diego (BS)
University of California, Los Angeles (PhD)
Awards Crafoord Prize (2017)
Nobel Prize in Physiology or Medicine (2025)
Scientific career
Institutions Parker Institute for Cancer Immunotherapy
Thesis Generation of lymphokine-activated killer cells from non-natural killer cell sources: Development from human thymocytes  (1988)
Academic advisorsSidney Golub [1]

Frederick Jay Ramsdell [1] (born December 4, 1960) [2] is an American-French [3] immunologist. As of 2025, he works at Sonoma Biotherapeutics. [2]

Contents

In 2025, he was jointly awarded the Nobel Prize in Physiology or Medicine with Mary E. Brunkow and Shimon Sakaguchi for their work in peripheral tolerance. [4]

Early life and education

Ramsdell was born on December 4, 1960, in Elmhurst, Illinois. [2]

He received a Bachelor of Science degree with a major in biochemistry and cell biology from the University of California, San Diego, in 1983. [5] In the same year, he enrolled at the University of California, Los Angeles, as a doctoral student, and studied microbiology and immunology under the mentorship of Sidney Golub, receiving his Doctor of Philosophy degree in 1987. [6]

Career

After earning his PhD, Ramsdell served a fellowship at the National Institutes of Health. After that, he joined the biopharmaceutical company Immunex, where his research focus was T cell activation and tolerance, and gene discovery. [6] [3] In 1994, he joined the Bothell, Washington-based biotechnology company Darwin Molecular (along with Mary E. Brunkow), where he established an immunology program. Darwin Molecular was acquired by Chiroscience in 1996. Three years later, Chiroscience merged with Celltech (briefly under the name Celltech Chiroscience). In 2004, Ramsdell and Brunkow left the company. [6] [7]

He joined ZymoGenetics in 2004 where he led research teams focusing on novel proteins with potential regulatory activity in lymphoid cells. [8] In 2008, he started working at Novo Nordisk where he helped establish the firm's Inflammation Research Center in Seattle and became leader of the immunobiology group. [8] [3]

Later, he served as vice president at aTyr Pharma in San Diego, [8] before joining the Parker Institute for Cancer Immunotherapy in San Francisco, where he was chief scientific officer. [6]

In 2019, he co-founded the San Francisco-based Sonoma Biotherapeutics with Jeffrey Bluestone, Qizhi Tang and Alexander Rudensky, [9] where he held the role of chief scientific officer. [10] As of 2025, he is the chair of the company's scientific advisory board. [11]

Research

Nobel Prize in Physiology or Medicine 2025: FoxP3 Treg cells in peripheral immune tolerance. 25-10-06-Nobel-Prize-FOXP3-Hegasy-v02.jpg
Nobel Prize in Physiology or Medicine 2025: FoxP3 Treg cells in peripheral immune tolerance.

In the 1990s, while working at Celltech in Bothell, Washington, Ramsdell and Brunkow studied a strain of mice, called scurfy, characterized by serious autoimmune disease, setting out to identify the mutation responsible for the phenotype. After establishing a candidate region on the X chromosome containing approximately 20 potential genes, they identified an insertion of two base pairs in a previously unknown gene, which they named Foxp3. In 2001, in collaboration with Hans D. Ochs, Robert Wildin, and their teams, Ramsdell and Brunkow demonstrated that mutations in the human FOXP3 gene are found in IPEX syndrome, a rare autoimmune disease. [12] [13]

Honors and awards

In 2017, Ramsdell received, jointly with Shimon Sakaguchi and Alexander Rudensky, the Crafoord Prize for research in polyarthritis. They were cited for "their discoveries relating to regulatory T cells, which counteract harmful immune reactions in arthritis and other autoimmune diseases". [14] [15]

Ramsdell was jointly awarded, with Sakaguchi and Mary E. Brunkow, the 2025 Nobel Prize in Physiology or Medicine. [4] On the day of the announcement, he was unable to be contacted to receive his prize as he was hiking off-the-grid in Idaho. [16] Ramsdell later told the BBC that his first response when he did learn the news from his wife was "I did not!", to which she replied that she had 200 text messages suggesting otherwise. [17]

References

  1. 1 2 "Generation of lymphokine-activated killer cells from non-natural killer cell sources: Development from human thymocytes". ProQuest . ProQuest   303705075 . Retrieved October 6, 2025.
  2. 1 2 3 "Nobel Prize in Physiology or Medicine 2025: Fred Ramsdell". NobelPrize.org . Retrieved October 6, 2025.
  3. 1 2 3 Harrington, Adam; McMillan, Natalie (October 6, 2025). "Scientist originally from Elmhurst, Illinois wins Nobel Prize in medicine". CBS News Chicago . Retrieved October 8, 2025.
  4. 1 2 "Nobel Prize in Physiology or Medicine 2025 Summary". NobelPrize.org. Retrieved October 6, 2025.
  5. "UC San Diego Alumnus Wins Nobel Prize in Physiology or Medicine". UC San Diego Today. University of California, San Diego. October 6, 2025. Retrieved October 8, 2025.
  6. 1 2 3 4 Schindler, Todd; Gondo, Nancy (October 6, 2025). "UCLA alumnus Fred Ramsdell wins 2025 Nobel Prize in physiology or medicine". UCLA Newsroom. University of California, Los Angeles . Retrieved October 8, 2025.
  7. Stiffler, Lisa (October 7, 2025). "How a scrappy biotech startup backed by Microsoft's co-founders set the stage for two Nobel winners". GeekWire . Retrieved October 8, 2025.
  8. 1 2 3 "About Fred Ramsdell, PhD – Chief Scientific Officer" (PDF). Parker Institute for Cancer Immunotherapy . Retrieved October 8, 2025.
  9. Eisenstein, Michael (June 16, 2021). "Sonoma Biotherapeutics: rallying the regulators". Nature Biotechnology . doi:10.1038/d41587-021-00008-4 . Retrieved October 8, 2025.
  10. Pashricha, Akash (August 6, 2021). "A life sciences startup will base its headquarters in both Seattle and California. It's far from the only one". The Seattle Times . Retrieved October 6, 2025.
  11. "Sonoma Biotherapeutics Congratulates Fred Ramsdell, PhD, Co-Founder and Scientific Advisory Board Chair, on Receiving the 2025 Nobel Prize in Physiology or Medicine for his work in Immunotherapy and Breakthrough Understanding of the Role of Regulatory T cells (Tregs)". Sonoma Biotherapeutics. October 6, 2025. Retrieved October 8, 2025.
  12. Naddaf, Miryam; Gibney, Elizabeth (October 6, 2025). "Medicine Nobel goes to scientists who revealed secrets of immune system 'regulation'". Nature . doi:10.1038/d41586-025-03193-3 . Retrieved October 8, 2025.
  13. Karlsson Hedestam, Gunilla; Kämpe, Olle (October 6, 2025). "Scientific background 2025: Immune tolerance: The identification of regulatory T cells and FOXP3" (PDF). nobelprize.org. Nobel Assembly at the Karolinska Institute . Retrieved October 8, 2025.
  14. "The Crafoord Prize in Polyarthritis 2017". CrafoordPrize.se . Archived from the original on January 12, 2017. Retrieved April 6, 2019.
  15. "Sakaguchi, Ramsdell, Rudensky win Crafoord Prize for discoveries in immune regulation". CancerLetter.com . January 13, 2017. Retrieved October 6, 2025.
  16. France-Presse, Agence (October 6, 2025). "Nobel committee unable to reach prize winner who is 'living his best life' hiking off grid". The Guardian . ISSN   0261-3077 . Retrieved October 7, 2025.
  17. Chater, James (October 8, 2025). "Scientist's off-grid hike interrupted by news of Nobel Prize win". BBC News. Retrieved October 8, 2025.